🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assessment of the efficacy and safety of Regorafenib and Avelumab in patien...
Status
Unknown
Location
Institut Bergonié
Start Date
2018-05-04
Trial ID
NCT03475953
This is an open label, multi-center, Phase 1/2 dose escalation study of BBI...
Status
Completed
Location
Mayo Clinic Campus in Arizona
Start Date
2014-01
Trial ID
NCT02024607
Treatments Being Tested
The purpose of the study is to measure high grade (3-5) toxicity of regoraf...
Status
Completed
Location
Mayo Clinic
Start Date
2015-03
Trial ID
NCT02466009
Treatments Being Tested
This is a phase 1 study of sildenafil in combination with regorafenib in pa...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-07-01
Trial ID
NCT02466802
Treatments Being Tested
An open label, three way crossover study to determine the effect of a high ...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01002378
To see how effective the study medicine combined with hormone therapy is wh...
Status
Recruiting
Location
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2022-06-28
Trial ID
NCT05113368
Treatments Being Tested
Open label Phase I study of Regorafenib to evaluate cardiovascular safety, ...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01339104
Treatments Being Tested
This study evaluates the interest of regorafenib in combination of metronom...
Status
Recruiting
Location
CHU de Besançon
Start Date
2023-05-09
Trial ID
NCT05462613
The study compares the efficacy and safety of regorafenib alone or in combi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-04-25
Trial ID
NCT05963490
Treatments Being Tested
The investigators propose a phase II clinical trial with the objective to i...
Status
Completed
Location
CHU de Besançon
Start Date
2020-10-16
Trial ID
NCT04534218
Treatments Being Tested